← Back

AmCad BioMed Corporation

AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices, primarily in Taiwan. Its products are aimed at the early detection and diagnosis of various diseases, and include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules, and AmCAD-UO for detecting obstructive sleep apnea in awake patients. The company is also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems, and AmCAD-UB, an AI solution for breast lesion detection. AmCad BioMed was incorporated in 2008 and is based in Taipei City, Taiwan.

Price · split & dividend adjusted
News & notes moving 4188.TWO